Systematic reviews of resection of metastases in metastatic colorectal cancer.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e16530-e16530
Author(s):  
M. Edwards ◽  
Z. Zhao ◽  
S. Chadda ◽  
B. Barber
2020 ◽  
Vol 27 (7) ◽  
pp. 2389-2401 ◽  
Author(s):  
Dominik Paul Modest ◽  
Volker Heinemann ◽  
Gunnar Folprecht ◽  
Timm Denecke ◽  
Johann Pratschke ◽  
...  

2006 ◽  
Vol 53 (2) ◽  
pp. 51-55 ◽  
Author(s):  
Irene Kuehrer

Background: Metastases to the liver is the leading cause of death in patients with colorectal cancer. Methods: The authors review the data on diagnosis and management of this clinical problem, and they discuss management options that can be considered. Results: Complete surgical resection of metastases from colorectal cancer that are localized to the liver results in 5-year survival rates ranging from 26% to 40%. Conclusions: By adding modalities such as targeted systemic therapy and other "local" treatments for liver metastases, further gains in survival are anticipated.


2021 ◽  
Vol 23 (1) ◽  
pp. 42-42

This publication is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review: Mocellin S, Baretta Z, Roqu i Figuls M, Sol I, Martin-Richard M, Hallum S, Bonfill Cosp X. Second-line systemic therapy for metastatic colorectal cancer. Cochrane Database of Systematic Reviews 2017, Issue 1. Art. No.: CD006875. DOI: 10.1002/14651858.CD006875.pub3.


Sign in / Sign up

Export Citation Format

Share Document